Webinar: “Upstream Approaches” to Build Resiliency: Organizational and Leadership...

Join this webinar on Tuesday, August 24, 3:00-4:00 pm ET.

Aug 18, 2021 | Beth Hess

  • Webinar, COVID-19

    Webinar: Cultural Contexts of Resilience and Vulnerability: Global Lessons from the...

    Join this webinar on Thursday, September 2, 3:00-4:00 pm ET.

    Aug 05, 2021 | Beth Hess

  • Webinar, COVID-19, Maternal, Child, & Adolescent Health

    Webinar: CDC Federal Snapshot: K-12 Guidance Update

    Join this webinar on Tuesday, August 17, 3:00-4:30 pm ET.

    Aug 05, 2021 | Beth Hess

  • COVID-19

    FDA Authorizes Expanded Use for REGEN-COV mAb

    The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

    Aug 05, 2021 | Guest Author

  • Webinar, Community Resilience, COVID-19

    Webinar: “Upstream Approaches” to Build Resiliency: Organizational and Leadership Strategies

    Join this webinar on Tuesday, August 24, 3:00-4:00 pm ET.

    Aug 18, 2021 | Beth Hess

    Webinar, COVID-19

    Webinar: Cultural Contexts of Resilience and Vulnerability: Global Lessons from the COVID-19 Pandemic

    Join this webinar on Thursday, September 2, 3:00-4:00 pm ET.

    Aug 05, 2021 | Beth Hess

    Webinar, COVID-19, Maternal, Child, & Adolescent Health

    Webinar: CDC Federal Snapshot: K-12 Guidance Update

    Join this webinar on Tuesday, August 17, 3:00-4:30 pm ET.

    Aug 05, 2021 | Beth Hess

    COVID-19

    FDA Authorizes Expanded Use for REGEN-COV mAb

    The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

    Aug 05, 2021 | Guest Author

    3 Newsletters1200 1

    PARTNER ARTICLES

    Back to Top